pirfenidone has been researched along with Pancreatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| C Jacob, HK; Dawra, RK; Dudeja, V; Edwards, DB; Ferrantella, A; George, J; Giri, B; Gomez Aguilar, B; Iyer, S; Jain, T; Maynard, CL; Palathingal Bava, E; Sahay, P; Saluja, AK; Sethi, V; Sharma, P; Tarique, M; Vaish, U | 1 |
| El-Agamy, DS; El-Kashef, DH; Shaaban, AA | 1 |
2 other study(ies) available for pirfenidone and Pancreatitis
| Article | Year |
|---|---|
Pirfenidone increases IL-10 and improves acute pancreatitis in multiple clinically relevant murine models.
Topics: Acinar Cells; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cytokines; Disease Models, Animal; Fibrosis; Interleukin-10; Macrophages; Mice; Pancreas; Pancreatitis; Paracrine Communication; Pyridones; Signal Transduction | 2022 |
Protective role of pirfenidone against experimentally-induced pancreatitis.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Arginine; Cytokines; Disease Models, Animal; Male; Mice; Oxidative Stress; Pancreas; Pancreatic Function Tests; Pancreatitis; Pyridones | 2019 |